Memorial Sloan Kettering Cancer Center and OpenEvidence announced a partnership on September 16, 2026, that pairs the integration of OpenEvidence's medical AI platform into MSK's Epic electronic health record workflow with the integration of OncoKB, MSK's precision oncology knowledge base, directly into OpenEvidence for broader use by providers outside MSK. How the Integration Works at the Point of Care The partnership includes both the integration of OpenEvidence within MSK's Epic workflow and…
This article has been indexed from Unite.AI
Read the original article: